SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-002522
Filing Date
2019-02-14
Accepted
2019-02-14 15:26:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G sc13g0219a4lfwoodford_thera.htm SC 13G/A 79251
  Complete submission text file 0001213900-19-002522.txt   81075
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88552 | Film No.: 19605347
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WOODFORD INVESTMENT MANAGEMENT LTD 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN
Business Address C/O WOODFORD INVESTMENT MANAGEMENT LTD 9400 GARSINGTON ROAD OXFORD X0 OX4 2HN 0044186580 9041
LF Woodford Equity Income Fund (Filed by) CIK: 0001637243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A